ESRRB and breast carcinoma: To validate the correlation of ERRβ overexpression with increased survival rates in breast cancer patients, the authors verified the increase in ERRβ expression following MLN4924 treatment, along with the upregulation of ERRβ target genes such as p21 and E-cadherin58.